Form 4: Inari Medical Director Mead Disposes of Shares in Merger with Stryker

Director Dana G. Mead Jr. reports the disposition of Inari Medical shares following the company's merger with Stryker Corporation, where each share was converted to $80.00 in cash.

Summary

• Dana G. Mead Jr., a director of Inari Medical, Inc., filed a Form 4 on February 19, 2025, reporting changes in beneficial ownership of the company's stock.
• The filing indicates that on February 19, 2025, Inari Medical merged with Eagle 1 Merger Sub, Inc., a subsidiary of Stryker Corporation, with Inari Medical surviving as a wholly-owned subsidiary of Stryker.
• As a result of the merger, each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Mead's holdings of 11,148 shares of common stock, including 4,126 restricted stock units (RSUs), were cancelled and converted into the right to receive the merger consideration.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as the merger provides a clear cash value to shareholders, but it also marks the end of Inari Medical as an independent entity.

Positives

• The merger provided shareholders with a cash payment of $80.00 per share.

Future Outlook

The document does not contain forward-looking statements beyond the completion of the merger.

Industry Context

The acquisition of Inari Medical by Stryker Corporation reflects ongoing consolidation trends in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Mergers and acquisitions are common in the medical device industry, with valuations often based on revenue multiples or strategic fit.
• Comparable acquisitions include [hypothetical example] Medtronic's acquisition of a smaller vascular device company at a similar revenue multiple.
• The $80.00 per share valuation would need to be compared to other recent transactions in the venous disease treatment space to assess its relative value.

Key Dates

Keywords

Merger, Inari Medical, Stryker, Form 4, Beneficial Ownership, Mead, NARI, Acquisition